Almac Group to Create 1,800 New Jobs Globally

November 8, 2021

Significant investment drives expansion offering opportunities over next 3 years

Craigavon, N.I. Almac Group, the global contract pharmaceutical development and manufacturing organisation, is planning to recruit 1,800 new jobs across its global operations over the next three years.

These new jobs include operational, supervisory and managerial roles across its business and offers an exciting variety of opportunities for both graduates and experienced candidates alike. Positions are available immediately across 120 different job roles at its sites in the UK, Ireland, North America, Singapore, Japan and the Nordic region.

The company, which marked 50 years in business in 2018, is at the forefront of the development, manufacturing, testing and distribution of essential medicines to vulnerable patients across the globe. Over the past 18 months, Almac has been instrumental in providing support to over 140 separate crucial research projects for COVID-19 vaccines and treatments through a range of service areas.

Almac Group has experienced continued growth in revenue and employee numbers annually over the past 15 years and with significant investment in expansion projects planned over the next three years, the company will see its headcount rise to 8,000 across its 19 facilities globally. Earlier this year the Group reported £677.3 million turnover for its financial year 2019/20 – an increase of £43 million (6%) from the previous year.

With 100% of the Group’s profits reinvested into the business, Almac has already committed to a number of significant expansion and improvement projects across its sites. These new roles will support this ongoing investment.

Alan Armstrong, Almac Group CEO, commented: “Almac’s mission is to “advance human health” and we are proud to be supporting so many global clients as they develop their life-saving treatment for patients in need.

He continued “As demand for our services steadily increases, our aim is to continue to grow our global team by actively recruiting 1,800 new individuals across a wide variety of diverse and exciting areas.  These roles come with a range of benefits including flexible working, competitive salary and an annual bonus.  Crucially this offers individuals the chance to help us continue our provision of solutions whilst making a real and positive contribution to health right across the world.”

To find out more, visit www.almacgroup.com/careers.

ENDS

About Almac Group

The Almac Group is an established contract development and manufacturing organisation providing an extensive range of integrated services across the drug development lifecycle to the pharmaceutical and biotech sectors globally. Its innovative services range from R&D, biomarker discovery development and commercialisation, API manufacture, analytical services, formulation development, clinical trial supply, IRT (IVRS/IWRS) through to commercial-scale manufacture.

The international company is a privately owned organisation which has grown organically over the past five decades now employing over 6,000 highly skilled personnel across 19 facilities including Europe, the US and Asia.

The figures quoted in this announcement relate to the financial period 1 October 2019 to 30 September 2020.

To keep up to date with latest news, follow us on Twitter and LinkedIn or visit almacgroup.com.

Share

Back to news